IGMS

IGM Biosciences
IGMS

Overview Fund Activity
Delisted

IGMS was delisted on the 13th of August, 2025.

Back to rankings

92 hedge funds and large institutions have $402M invested in IGM Biosciences in 2022 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 30 increasing their positions, 28 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
92
Holders Change
+3
Holders Change %
+3.37%
% of All Funds
1.59%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
18
Increased
30
Reduced
28
Closed
14
Calls
$1.54M
Puts
$670K
Net Calls
+$866K
Net Calls Change
-$886K

Top Buyers

1
AG
1
Artal Group
Luxembourg
$55.7M
2
D.E. Shaw & Co
2
D.E. Shaw & Co
New York
$7.67M
3
Goldman Sachs
3
Goldman Sachs
New York
$5.67M
4
CS
4
Candriam SCA
Luxembourg
$1.11M
5
State Street
5
State Street
Massachusetts
$5.05M

Top Sellers

1
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$50.4M
2
Millennium Management
2
Millennium Management
New York
$6.62M
3
Alkeon Capital Management
3
Alkeon Capital Management
New York
$21.9M
4
Voloridge Investment Management
4
Voloridge Investment Management
Florida
$885K
5
HF
5
HRT Financial
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CAPTRUST Financial Advisors
101
CAPTRUST Financial Advisors
North Carolina
– -$50K -2,750 Closed
ACM
102
Aquatic Capital Management
Illinois
– -$11K -600 Closed
SOW
103
State of Wyoming
Wyoming
– -$5K -269 Closed
PFS
104
Prospera Financial Services
Texas
– -$2K -98 Closed
1 2 3 4
5